Onset of Action for Oxycodone ER
Oxycodone extended-release (ER) has an onset of action of approximately 45-60 minutes, with peak analgesic effects occurring at 2-4 hours after administration 1, 2.
Pharmacokinetic Profile
The absorption of oxycodone ER follows a bi-exponential pattern 3:
- Rapid phase: Mean half-life of 37 minutes, accounting for 38% of the dose
- Slow phase: Half-life of 6.2 hours, accounting for 62% of the dose
The time to maximum concentration (Tmax) for ER formulations ranges from 1.4 to 2.6 hours depending on the dose 1. This is notably slower than immediate-release (IR) oxycodone, which has a Tmax of approximately 1.3 hours 1.
Clinical Implications
For breakthrough pain, ER oxycodone is NOT appropriate due to its delayed onset. The FDA label explicitly states that ER formulations should be administered on a regularly scheduled basis every 4-6 hours for chronic pain management, not for acute pain episodes 1.
Key Timing Considerations:
- Median time to onset of relief: Approximately 46 minutes for ER oxycodone 30 mg 2
- Peak pain relief: 2-4 hours post-administration 2
- Duration of action: 10-12 hours (compared to 7 hours for IR formulations) 2
Important Caveats
Food significantly affects absorption: A high-fat meal increases AUC by 27% and delays Tmax from 1.25 to 2.54 hours 1. This means onset may be further delayed when taken with food.
Steady-state considerations: It takes approximately 18-24 hours to reach steady-state plasma concentrations with ER oxycodone 1. This means full therapeutic effect may not be achieved until the second day of around-the-clock dosing.
For acute breakthrough pain in cancer patients, guidelines recommend using concentrated oral morphine solution (20 mg/mL) or oral oxycodone IR solution (20 mg/mL) for oral or sublingual administration instead of ER formulations 4.